Atea Pharmaceuticals

/files/logo_portfolio/200x200_resize_ATEA-logo.png
Site
Stage of funding:Completed
Therapeutic group:Infectious Diseases
Type:Drug

Description

Atea Pharmaceuticals, Inc. is an emerging biopharmaceutical company which is engaged in the acquisition, discovery and development of novel antiviral therapeutics for RNA-based viruses. The company is engaged in clinical programs for treatment of life-threatening viral infections: COVID-19 (lead program), Hepatitis C, Respiratory syncytial virus (RSV) and Dengue fever.

Return

Portfolio companies news